PTC Therapeutics (PTCT) PT Raised to $37 at Goldman Sachs, 'stock in an increasingly precarious position ahead of higher risk'

Go back to PTC Therapeutics (PTCT) PT Raised to $37 at Goldman Sachs, 'stock in an increasingly precarious position ahead of higher risk'

Form 8-K PTC THERAPEUTICS, INC. For: May 17

May 17, 2023 7:05 AM EDT

... More